World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
23408
World Ranking
9464
National Ranking
4176

Megan S. Lim publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Megan S. Lim sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 309 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Megan S. Lim D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Megan S. Lim sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 64 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Megan S. Lim is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine, with a significant emphasis on pathology and forensic medicine, oncology, immunology, genetics, and molecular biology. Within these fields, their main topics of work include lymphoma diagnosis and treatment, viral-associated cancers and disorders, chronic lymphocytic leukemia research, CAR-T cell therapy research, cancer genomics and diagnostics, CNS lymphoma diagnosis and treatment, and immune cell function and interaction.

They have authored several recent papers, demonstrating engagement with hematolymphoid tumor classification, lymphoid neoplasms, and clinical oncology guidelines. Notable publications include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms (2022) published in Leukemia
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022) published in Leukemia
  • International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease (2020) published in Blood Advances
  • NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021 (2021) published in Journal of the National Comprehensive Cancer Network
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology (2020) published in PubMed

Their frequent co-authors include David C. Fajgenbaum, Kojo S.J. Elenitoba-Johnson, Sheila K. Pierson, Adam Bagg, and Frits van Rhee. These collaborations have contributed to a broad range of publications within prominent medical and oncological topics.

The primary venues where Megan S. Lim has published include:

  • Blood
  • Leukemia Research
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Leukemia

Best Publications

  • Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

    Yael P Mossé;Megan S Lim;Stephan D Voss;Keith Wilner

  • Skp2 is oncogenic and overexpressed in human cancers

    Matthias Gstaiger;Richard Jordan;Megan Lim;Charles Catzavelos

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis

    Michael C. Sneller;Jin Wang;Janet K. Dale;Warren Strober

  • International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

    Frits Van Rhee;Peter Voorhees;Angela Dispenzieri;Alexander Fosså

  • Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

    Yael P. Mossé;Stephan D. Voss;Megan S. Lim;Delphine Rolland

  • High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.

    Noah A. Brown;Larissa V. Furtado;Bryan L. Betz;Mark J. Kiel

  • Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma

    Mark J. Kiel;Thirunavukkarasu Velusamy;Bryan L. Betz;Lili Zhao

  • Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome

    Megan S. Lim;Stephen E. Straus;Janet K. Dale;Thomas A. Fleisher

  • Activating FGFR2-RAS-BRAF mutations in ameloblastoma.

    Noah A. Brown;Delphine Cm Rolland;Jonathan B. McHugh;Helmut C. Weigelin

  • Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

    Mark J. Kiel;Thirunavukkarasu Velusamy;Delphine Rolland;Anagh A. Sahasrabuddhe

  • Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma

    Kojo S.J. Elenitoba-Johnson;Randy D. Gascoyne;Megan S. Lim;Mukesh Chhanabai

  • Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

    David A Wada;Mark E Law;Eric D Hsi;David J DiCaudo

  • Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

    Kojo S. J. Elenitoba-Johnson;Stephen D. Jenson;Robert T. Abbott;Robert A. Palais

  • The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells

    Nancy M. Joseph;Jack T. Mosher;Johanna Buchstaller;Paige Snider

  • mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion

    Jae Y. Lee;Daisuke Nakada;Omer H. Yilmaz;Zuzana Tothova

  • Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome

    Mark J. Kiel;Anagh A. Sahasrabuddhe;Delphine C.M. Rolland;Thirunavukkarasu Velusamy

  • GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.

    Tianjiao Wang;Andrew L. Feldman;David A. Wada;Ye Lu

  • Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.

    Megan S. Lim;Ann Adamson;Zhaosheng Lin;Bayardo Perez-Ordonez

  • High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.

    Aaron M. Udager;Delphine C.M. Rolland;Jonathan B. McHugh;Bryan L. Betz

Frequent Co-Authors

Kojo S.J. Elenitoba-Johnson
Kojo S.J. Elenitoba-Johnson Memorial Sloan Kettering Cancer Center
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center
Yoon Kyung Jeon
Yoon Kyung Jeon Seoul National University Hospital
Maryalice Stetler-Stevenson
Maryalice Stetler-Stevenson National Institutes of Health
Sibrand Poppema
Sibrand Poppema Sunway University
Alexey I. Nesvizhskii
Alexey I. Nesvizhskii University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens the door to a wide range of career opportunities, especially with the flexibility of online education. Many students start their healthcare journeys through transitional programs like a medical assistant to lpn bridge program online, allowing for progressive professional growth.

For those looking to fast-track their undergraduate education, there are online biology degree programs that offer accelerated courses. These are ideal for students eager to enter the workforce or pursue graduate studies more quickly.

Nursing is another closely related field, with options like an online asn program providing foundational nursing skills that can complement a science background or serve as a standalone healthcare pathway.

Nutrition is also a growing area, with careers ranging from clinical dietetics to wellness consulting. If you’re considering this specialty, an online dietitian degree can prepare you for professional credentialing and practice.

These flexible online options make it easier than ever to begin or advance your career in the sciences and healthcare, letting you tailor your education to your specific interests and goals.

Best Scientists Citing Megan S. Lim

Trending Scientists

Recently Published Articles